Nicholas Investment Partners, LP Nevro Corp Transaction History

Nicholas Investment Partners, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$61.52 - $91.1 $5.26 Million - $7.8 Million	-85,577 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$58.04 - $66.99 $961,838 - $1.11 Million	-16,572 Reduced 16.22%	85,577 $5.55 Million
Q1 2019 May 15, 2019	SELL	$35.52 - $62.62 $465,596 - $820,822	-13,108 Reduced 11.37%	102,149 $6.39 Million
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $4.08 Million - $6.49 Million	115,257 New	115,257 $4.48 Million
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $1.43 Million - $1.83 Million	-19,793 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $325,975 - $415,659	4,693 Added 31.08%	19,793 $1.72 Million
Q4 2017 Feb 14, 2018	SELL	$65.94 - $93.31 $456,041 - $645,331	-6,916 Reduced 31.41%	15,100 $1.04 Million
Q3 2017 Nov 13, 2017	BUY	$80.87 - $91.08 $1.78 Million - $2.01 Million	22,016	22,016 $2 Million

150

37.8M

542K

1.48M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $202M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.